You are using an outdated browser. If you would like to use our website, please use Chrome, Firefox, Safari or other browser
Site Exit Disclaimer
You are now leaving the website of Merck KGaA, Darmstadt, Germany’s biopharma business. This link may lead to a resource maintained by third parties over whom we have no control. As such, we are not responsible for and makes no representation as to the accuracy or any other aspect of such resource or the privacy practices of such third party. Providing links to a third party website does not constitute an endorsement by our company of such website or the information or products presented on such website.
Share Disclaimer
By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.
Cookie Disclaimer
We use cookies in our website to give you the most relevant experience. By clicking or navigating the site, you are accepting the use of all our cookies according to our Cookie Policy / Privacy Statement. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.
Cookie Disclaimer
These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., setting the language).
These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.
These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., setting the language).
Approximately one in 400 Canadians live with MS.1 Every one of those people has a community of family, carers and even other patients sharing in the experience of living with a degenerative disease. We work with the people who experience it first-hand every day to better understand the emotional and practical impacts of MS. As we further our research, develop medications and help raise awareness, we do so in direct response to what we learn.
More on MS
Multiple Sclerosis (MS) is a chronic disease of the central nervous system, which includes the brain, spinal cord and optic nerves. The disease attacks myelin sheath, the protective covering around the nerves in the brain and spinal cord, causing inflammation and other damages.1 These damages can cause a disruption in communication from the brain to the nerve cells, affecting one’s ability to perform basic functions like speaking, seeing and walking.2
Canada has one of the highest rates of MS in the world, with one in every 400 people living with the disease.3 MS is most often diagnosed in young adults aged 15-40, but children and older adults can also be diagnosed with the disease.4
The effects of MS can be physical, emotional and financial.
Physical symptoms can include:5
extreme fatigue
lack of coordination
weakness
tingling
impaired sensations
vision problems
bladder problems
cognitive impairment
mood changes.
There is currently no cure to MS, but every day, researchers are learning more about what causes the disease and are zeroing in on ways to prevent it.6
MS From the Inside Out
The 10-minute VR experience takes users through the brain of someone living with MS. It explores the complex science of the disease and simulates five typical visual and auditory symptoms of MS.
Footnotes
[1] [2] [3] [4] [5] [6] MS Society of Canada. What is MS. Accessed December 20, 2023. Available at: https://mscanada.ca/about-ms
